Original Article
‘CROSS’-ing into the ‘Real World’: a retrospective cohort study of patients receiving trimodality and bimodality therapy for esophageal cancer
Journal of Gastrointestinal Oncology
2023;
14
(2)
:480-493
.
(29 April 2023)
Haematological and nutritional prognostic biomarkers for patients receiving CROSS or FLOT
Journal of Gastrointestinal Oncology
2023;
14
(2)
:494-503
.
(29 April 2023)
Network pharmacology prediction and molecular docking-based strategy to discover the potential pharmacological mechanism of action of Wang Bu Liu Xing (Semen vaccariae) for colorectal cancer
Journal of Gastrointestinal Oncology
2023;
14
(2)
:504-515
.
(29 April 2023)
KMO in the promotion of tumor development and progression in hepatocellular carcinoma
Journal of Gastrointestinal Oncology
2023;
14
(2)
:516-532
.
(29 April 2023)
Schisandrin B inhibits tumor progression of hepatocellular carcinoma by targeting the RhoA/ROCK1 pathway
Journal of Gastrointestinal Oncology
2023;
14
(2)
:533-543
.
(29 April 2023)
Clinical analysis of tubular stapler-assisted nested anastomosis in the prevention of postoperative esophageal cancer complications
Journal of Gastrointestinal Oncology
2023;
14
(2)
:544-553
.
(29 April 2023)
Lesion size, elevated morphology, and non or closed-type atrophy are predictive factors for gastric adenocarcinoma of the fundic gland type rather than oxyntic gland adenoma
Journal of Gastrointestinal Oncology
2023;
14
(2)
:554-562
.
(29 April 2023)
NDRG2 inhibition of glycolysis in liver tumor cells is regulated by SIRT1
Journal of Gastrointestinal Oncology
2023;
14
(2)
:563-571
.
(29 April 2023)
A systematic review and meta-analysis of nursing effect of fast-track recovery surgery on patients undergoing total endoscopic resection of esophageal cancer: fast-track recovery surgery vs. nursing care as usual
Journal of Gastrointestinal Oncology
2023;
14
(2)
:572-584
.
(29 April 2023)
RNA-binding protein ENO1 promotes the tumor progression of gastric cancer by binding to and regulating gastric cancer-related genes
Journal of Gastrointestinal Oncology
2023;
14
(2)
:585-598
.
(29 April 2023)
Development and validation of an inflammatory response-related gene and clinical factor-based signature for predicting prognosis in gastric cancer
Journal of Gastrointestinal Oncology
2023;
14
(2)
:599-616
.
(29 April 2023)
A case series of 10 patients undergone linear cutter/stapler guiding device-led overlapped esophagojejunostomy: a preliminary study
Journal of Gastrointestinal Oncology
2023;
14
(2)
:617-625
.
(29 April 2023)
Diagnostic value of liver contrast-enhanced ultrasound in early hepatocellular carcinoma: a systematic review and meta-analysis
Journal of Gastrointestinal Oncology
2023;
14
(2)
:626-635
.
(29 April 2023)
Identification of glutamyl-prolyl-tRNA synthetase as a new therapeutic target in hepatocellular carcinoma via a novel bioinformatic approach
Journal of Gastrointestinal Oncology
2023;
14
(2)
:636-649
.
(29 April 2023)
Identification and validation of a novel cuproptosis-related lncRNA signature for predicting colorectal cancer patients’ survival
Journal of Gastrointestinal Oncology
2023;
14
(2)
:650-662
.
(29 April 2023)
A single-center retrospective analysis of the efficacy and safety of a modified regimen of irinotecan plus S-1 (IRIS) with molecular targeting agents as second-line chemotherapy in Japanese patients with recurrent or nonresectable colorectal cancer
Journal of Gastrointestinal Oncology
2023;
14
(2)
:663-675
.
(29 April 2023)
Phase II study of biweekly cetuximab plus mFOLFOX6 or mFOLFIRI as second-line treatment for metastatic colorectal cancer and exploratory analysis of associations between DNA methylation status and the efficacy of the anti-EGFR antibody: T-CORE1201
Journal of Gastrointestinal Oncology
2023;
14
(2)
:676-691
.
(29 April 2023)
Effectiveness, safety, and prognostic factors of trifluridine/tipiracil for the treatment of patients with metastatic colorectal cancer in routine clinical practice
Journal of Gastrointestinal Oncology
2023;
14
(2)
:692-704
.
(29 April 2023)
Peptidomic changes in human serous colorectal cancer patients
Journal of Gastrointestinal Oncology
2023;
14
(2)
:705-718
.
(29 April 2023)
Identification and validation of the microRNAs and hub genes for pancreatic ductal adenocarcinoma by an integrated bioinformatic analysis
Journal of Gastrointestinal Oncology
2023;
14
(2)
:719-732
.
(29 April 2023)
Immune-related adverse events as independent prognostic factors for camrelizumab in patients with esophageal squamous cell carcinoma: a retrospective cohort study
Journal of Gastrointestinal Oncology
2023;
14
(2)
:733-743
.
(29 April 2023)
Role of epithelial cell-mesenchymal transition regulators in molecular typing and prognosis of colon cancer
Journal of Gastrointestinal Oncology
2023;
14
(2)
:744-757
.
(29 April 2023)
A retrospective cohort study on the efficacy and safety for combination therapy of immunotherapy, targeted agent, and chemotherapy versus immunochemotherapy or chemotherapy alone in the first-line treatment of advanced biliary tract carcinoma
Journal of Gastrointestinal Oncology
2023;
14
(2)
:758-767
.
(29 April 2023)
Evaluation of the up-to-7 criterion for determining the treatment of hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage B: a single-center retrospective cohort study
Journal of Gastrointestinal Oncology
2023;
14
(2)
:768-779
.
(29 April 2023)
Association between the systemic immune inflammation index and recurrence or metastasis after interventional therapy in patients with primary liver cancer- a retrospective cohort study
Journal of Gastrointestinal Oncology
2023;
14
(2)
:780-788
.
(29 April 2023)
Predictive value of apparent diffusion coefficient for neoadjuvant chemotherapy in locally advanced colorectal cancer patients
Journal of Gastrointestinal Oncology
2023;
14
(2)
:789-797
.
(29 April 2023)
The Frailty Index and colon cancer: a 2-sample Mendelian-randomization study
Journal of Gastrointestinal Oncology
2023;
14
(2)
:798-805
.
(29 April 2023)
Risk factors for sepsis in patients with colorectal cancer complicated with gastrointestinal perforation and its impact on prognosis
Journal of Gastrointestinal Oncology
2023;
14
(2)
:806-814
.
(29 April 2023)
Short-term clinical effects and inflammatory response of natural orifice specimen extraction surgery versus conventional laparoscopic-assisted surgery for the treatment of sigmoid and rectal cancer
Journal of Gastrointestinal Oncology
2023;
14
(2)
:815-823
.
(29 April 2023)
Expression and clinical significance of ENC1 in gastrointestinal tumors: Bioinformatics analysis based on a public gene database
Journal of Gastrointestinal Oncology
2023;
14
(2)
:824-832
.
(29 April 2023)
Hepatopancreatobiliary malignancies: time to treatment matters
Journal of Gastrointestinal Oncology
2023;
14
(2)
:833-848
.
(29 April 2023)
Hepatic arterial infusion chemotherapy and immune checkpoint inhibitors, alone or in combination, in advanced hepatocellular carcinoma with macrovascular invasion: a single-centre experience in Taiwan
Journal of Gastrointestinal Oncology
2023;
14
(2)
:849-862
.
(29 April 2023)
Phosphatase regenerating liver 3 participates in Integrinβ1/FAK-Src/MAPK signaling pathway and contributes to the regulation of malignant behaviors in hepatocellular carcinoma cells
Journal of Gastrointestinal Oncology
2023;
14
(2)
:863-873
.
(29 April 2023)
Overall survival and toxicity of hepatocellular carcinoma Barcelona Clinic Liver Cancer B patients receiving Y90 radioembolization: analysis of the radiation-emitting SIR-spheres in non-resectable liver tumor (RESiN) registry
Journal of Gastrointestinal Oncology
2023;
14
(2)
:874-885
.
(29 April 2023)
Primary tumor location impacts survival in colorectal cancer patients after primary resection: a population‑based propensity score matching cohort study
Journal of Gastrointestinal Oncology
2023;
14
(2)
:886-899
.
(29 April 2023)
NCAPG is transcriptionally regulated by CBX3 and activates the Wnt/β-catenin signaling pathway to promote proliferation and the cell cycle and inhibit apoptosis in colorectal cancer
Journal of Gastrointestinal Oncology
2023;
14
(2)
:900-912
.
(29 April 2023)
Risk factors of lymph node metastasis in patients with T1 stage colorectal cancer—a retrospective cohort study based on the Surveillance, Epidemiology, and End Results database
Journal of Gastrointestinal Oncology
2023;
14
(2)
:913-921
.
(29 April 2023)
Identification of gastric schwannoma and non-metastatic gastric stromal tumor by CT: a single-institution retrospective diagnostic test
Journal of Gastrointestinal Oncology
2023;
14
(2)
:922-931
.
(29 April 2023)
The combination of a prolonged treatment time window and alpha-fetoprotein benefits the tumor response of hepatocellular carcinoma patients as evaluated by the imRECIST: a single-center, retrospective study
Journal of Gastrointestinal Oncology
2023;
14
(2)
:932-942
.
(29 April 2023)
A surgical nursing perspective analysis of glucose variability in BCLC stage B–C hepatocellular carcinoma patients with and without T2D within 1 year of hepatectomy: a retrospective cohort study from 2016 to 2020
Journal of Gastrointestinal Oncology
2023;
14
(2)
:943-951
.
(29 April 2023)
Effect of negative emotions on patients with advanced gastric cancer receiving systemic chemotherapy: a prospective study
Journal of Gastrointestinal Oncology
2023;
14
(2)
:952-962
.
(29 April 2023)
Effects of magnetic resonance imaging (MRI)-detected extramural vascular invasion (mrEMVI) and tumor deposits (TDs) on distant metastasis and long-term survival after surgery for stage III rectal cancer: a retrospective study grouped based on the relationship between the bottom of the tumor and peritoneal reflection
Journal of Gastrointestinal Oncology
2023;
14
(2)
:963-979
.
(29 April 2023)
Bromodomain-containing protein 9 activates proliferation and epithelial-mesenchymal transition of colorectal cancer via the estrogen pathway in vivo and in vitro
Journal of Gastrointestinal Oncology
2023;
14
(2)
:980-996
.
(29 April 2023)
Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma
Journal of Gastrointestinal Oncology
2023;
14
(2)
:997-1007
.
(29 April 2023)
Suspicious findings observed retrospectively on CT imaging performed before the diagnosis of pancreatic cancer
Journal of Gastrointestinal Oncology
2023;
14
(2)
:1008-1018
.
(29 April 2023)
Identification of a potential competing endogenous RNA (ceRNA) network in gastric adenocarcinoma
Journal of Gastrointestinal Oncology
2023;
14
(2)
:1019-1036
.
(29 April 2023)
Paclitaxel combined with platinum (PTX) versus fluorouracil combined with cisplatin (PF) in the treatment of unresectable esophageal cancer: a systematic review and meta-analysis of the efficacy and toxicity of two different regimens
Journal of Gastrointestinal Oncology
2023;
14
(2)
:1037-1051
.
(29 April 2023)
Efficacy and safety of toripalimab with fruquintinib in the third-line treatment of refractory advanced metastatic colorectal cancer: results of a single-arm, single-center, prospective, phase II clinical study
Journal of Gastrointestinal Oncology
2023;
14
(2)
:1052-1063
.
(29 April 2023)
Exosomal miR-125b-5p derived from cancer-associated fibroblasts promotes the growth, migration, and invasion of pancreatic cancer cells by decreasing adenomatous polyposis coli (APC) expression
Journal of Gastrointestinal Oncology
2023;
14
(2)
:1064-1076
.
(29 April 2023)
Postoperative procalcitonin is a biomarker for excluding the onset of clinically relevant pancreatic fistula after pancreaticoduodenectomy
Journal of Gastrointestinal Oncology
2023;
14
(2)
:1077-1086
.
(29 April 2023)
Review Article
The predictive impact of dual somatostatin receptor/fluorodeoxyglucose (FDG) positron emission tomography (PET) in metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs): review of literature and a single institution experience
Journal of Gastrointestinal Oncology
2023;
14
(2)
:1087-1094
.
(29 April 2023)
A narrative review of intraoperative use of indocyanine green fluorescence imaging in gastrointestinal cancer: situation and future directions
Journal of Gastrointestinal Oncology
2023;
14
(2)
:1095-1113
.
(29 April 2023)
Advances in pre-treatment evaluation of pancreatic ductal adenocarcinoma: a narrative review
Journal of Gastrointestinal Oncology
2023;
14
(2)
:1114-1130
.
(29 April 2023)
Study Protocol
A small-scale, exploratory real-world study of nab-paclitaxel combined with oxaliplatin and tegafur in the perioperative treatment of advanced gastric cancer: a study protocol for a real-world clinical trial
Journal of Gastrointestinal Oncology
2023;
14
(2)
:1131-1140
.
(29 April 2023)
Case Series
Immune checkpoint inhibitors in liver transplant: a case series
Journal of Gastrointestinal Oncology
2023;
14
(2)
:1141-1148
.
(29 April 2023)
Case Report
Medullary carcinoma of the duodenum treated with pembrolizumab: a case report
Journal of Gastrointestinal Oncology
2023;
14
(2)
:1149-1154
.
(29 April 2023)
Surgery, radiotherapy, chemotherapy, targeted therapy, and immunotherapy of rectal adenocarcinoma with penile metastasis: a case report
Journal of Gastrointestinal Oncology
2023;
14
(2)
:1155-1165
.
(29 April 2023)
Conservative treatment of hepatic portal vein gas after transarterial chemoembolization treatment for liver metastasis of postoperative esophageal cancer: a case report
Journal of Gastrointestinal Oncology
2023;
14
(2)
:1166-1174
.
(29 April 2023)
Editorial
Immunotherapy for deficient mismatch repair (dMMR) pancreatic ductal adenocarcinoma
Journal of Gastrointestinal Oncology
2023;
14
(2)
:1175-1177
.
(29 April 2023)
The role of biomarker in later-line treatment for metastatic colorectal cancer
Journal of Gastrointestinal Oncology
2023;
14
(2)
:1178-1180
.
(29 April 2023)
